Cargando…
PI3K inhibitors protect against glucocorticoid-induced skin atrophy
BACKGROUND: Skin atrophy is a major adverse effect of topical glucocorticoids. We recently reported that REDD1 (regulated in development and DNA damage 1) and FKBP51 (FK506 binding protein 5), negative regulators of mTOR/Akt signaling, are induced by glucocorticoids in mouse and human skin and are c...
Autores principales: | Agarwal, Shivani, Mirzoeva, Salida, Readhead, Ben, Dudley, Joel T., Budunova, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441871/ https://www.ncbi.nlm.nih.gov/pubmed/30737086 http://dx.doi.org/10.1016/j.ebiom.2019.01.055 |
Ejemplares similares
-
Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin
por: Baida, Gleb, et al.
Publicado: (2020) -
Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy
por: Baida, Gleb, et al.
Publicado: (2018) -
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
por: Baida, Gleb, et al.
Publicado: (2015) -
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin
por: Klopot, Anna, et al.
Publicado: (2015) -
Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor
por: Mirzoeva, Salida, et al.
Publicado: (2018)